Research
Research

Brain Tumors May Hijack Neurons to Survive

By Claire Ashworth ·

How Tumors Talk to Neurons

A new peer-reviewed review published in the journal Psychedelics reveals that glioma cells can integrate into healthy brain tissue. The findings come from existing laboratory studies, not fresh experiments. Researchers observed how tumors form synapse-like connections with surrounding neurons.

The study highlights a strange biological mechanism. Glioma cells do not just grow passively. They actively communicate with neural networks. This eavesdropping behavior allows the tumor to access nutrients and signals from healthy brain cells.

The review details how glioma cells use glutamate signaling to establish these links. Glutamate is a key neurotransmitter in the brain. By tapping into this system, tumors can manipulate their microenvironment. This process helps them evade the immune system and resist treatment.

Could Psychedelics Disrupt This Connection?

The implications are significant for cancer therapy. If tumors can hijack neural pathways, standard chemotherapy may struggle to reach them. The blood-brain barrier already limits drug delivery. Adding neural communication makes the problem more complex.

The journal Psychedelics suggests that certain compounds might interfere with glutamate signaling. Psychedelics are known to modulate brain chemistry. If they can alter how neurons and tumor cells communicate, they could potentially starve the tumor of its neural support.

This is still an early-stage hypothesis. The review does not claim psychedelics cure cancer. It opens a new line of inquiry. Future clinical trials will need to test whether these drugs can break the tumor-neuron link.

Frequently Asked Questions

Can glioma cells really form synapses with neurons? Yes. Laboratory studies show they create functional, synapse-like contacts. This allows them to draw nutrients and signals from healthy tissue.

Are psychedelics proven to treat cancer? No. The review proposes a mechanism but does not confirm efficacy. Clinical trials are needed to test this hypothesis.

What role does glutamate play in this process? Glutamate serves as the chemical messenger. Tumors exploit this signaling to integrate into neural networks and sustain their growth.